Skip to content
OpenCapital
Get started

Corbus Pharmaceuticals CRBP Q4 2024 Annual earnings

Reported March 11, 2025 · Before market open

EPS-$0.78Beat by $0.24
EPS estimate-$1.02

Next report

Aug 11, 2026 (In 1 week)
EPS estimate-$1.30

Versus estimates

Diluted EPS

Q1 2026-$1.23Beat by $0.03Q4 2025-$1.25Beat by $0.53Q3 2025-$1.90Miss by $0.10Q2 2025-$1.44Beat by $0.11Q1 2025-$1.39Miss by $0.13
Q4 2024-$0.78Beat by $0.24

Ask the moment Corbus Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Corbus Pharmaceuticals report Q4 2024 earnings?
Corbus Pharmaceuticals (CRBP) reported Q4 2024 earnings on March 11, 2025 before market open.
What were Corbus Pharmaceuticals's Q4 2024 revenue and EPS?
Corbus Pharmaceuticals reported eps of $-0.78 for Q4 2024.
Did Corbus Pharmaceuticals beat estimates in Q4 2024?
EPS beat the consensus estimate of $-1.02 by $0.24.
Where can I find Corbus Pharmaceuticals's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-037335) directly on SEC EDGAR. The filing index links above go to sec.gov.